ICBC: Spanish Medical Cannabis Subcommittee Holds First Hearing

ICBC: Spanish Medical Cannabis Subcommittee Holds First Hearing

It doesn’t sound as though it’s anything more than what we’d call a circlefest with negative nellies in the ascendancy A key subcommittee tasked with exploring medical cannabis reform and regulations finally met in Spain, which will hopefully help yield future movement. Per (translated to English): The subcommission for the purpose of carrying out experiments in the regulation of cannabis for medicinal use , created in the Congress of Deputies to study a possible regulation in Spain, has hosted the first session of appearances on Tuesday. As approved by this commission a few weeks ago, there will be 26 experts who will tell their experience on this matter until the end of June. Among the most outstanding is that of Manuel Ibarra Lorente , head of the Drug Inspection and Control Department of the Spanish Agency for Medicines and Health Products (AEMPS) , who has provided the technical vision of the regulatory body in Spain, of its possible regulation. of the authorized clinical trials with cannabinoids and about the doubts that currently exist. During the subcommittee meeting, Ibarra expressed doubt regarding the notion that “cannabis has multiple therapeutic benefits in many other indications: relief of chronic pain, prevention of nausea and vomiting, as an appetite stimulant, reducing depression, anxiety or disorders of the dream.” Ibarra is pushing for a very controlled and regulated medical cannabis industry in Spain, and even then, only after a considerable amount of further research is conducted. Hopefully fellow committee members are listening to other sources, and not solely relying on Ibarra’s opinion.

Excerpt only …
Source : ICBC: Spanish Medical Cannabis Subcommittee Holds First Hearing

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.